Telemedicine
Conditions
Brief summary
This prospective study will include both an intervention and control arm. The control arm will receive face-to-face pharmacy clinic visits per standard of care. The intervention arm will receive pharmacy clinic visits plus additional telephone follow-up. Patients with a hemoglobin A1c in the last 3 months greater than 9% will be eligible. Eligible patients must have a primary care physician at Johns Hopkins Outpatient Center (JHOC) or East Baltimore Medical Center (EBMC). Purpose: To compare the change in hemoglobin A1c over the 3 month study period in the intervention group in which patients participate in telemedicine, to a control group in which they do not
Interventions
OTHERTelemedicine
The intervention arm will receive pharmacy clinic visits plus additional telephone follow-up.
Sponsors
Johns Hopkins University
Study design
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
OTHER
Masking
NONE
Eligibility
Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No
Inclusion criteria
* Adult patients with a primary care provider at JHOC or EMBC * Patients have seen primary care provider within last 6 months * Patients with hemoglobin A1c greater than 9%
Exclusion criteria
* Patients \<18 years of age * Patients with previously established care with JHH ambulatory care pharmacist * Patients with communication barriers who do not have a caregiver * Patients with new diagnosis of diabetes * Patients who are pregnant or planning to become pregnant during the time of the study * Patients followed by Endocrinology or Diabetes Center
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Change in hemoglobin A1c | 3 months | A1c at 3 months - A1c at Baseline |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Patient adherence to office visits (# visits attended/# of visits scheduled) | 3 months | \# visits attended/# of visits scheduled |
| Pharmacist interventions (Number of pharmacist interventions (lifestyle or medication changes) made) | 3 months | Number of pharmacist interventions (lifestyle or medication changes) made |
| Patient satisfaction (Based on survey results) | 3 months | Based on survey results at final pharmacy clinic visit |
| Telemedicine in Usual Care (Percent of patients who receive telephone call under usual care) | 3 months | Percent of patients who receive telephone call under usual care |
| Telemedicine Adherence (Percent of telephone encounters completed in intervention arm) | 3 months | Percent of telephone encounters completed in intervention arm |
Outcome results
None listed